Sickle Cell Anemia
Showing 1 - 25 of 122
Sickle Cell Disease, Sickle Cell Anemia, Osteonecrosis Trial (Alendronate Sodium)
Not yet recruiting
- Sickle Cell Disease
- +4 more
- Alendronate Sodium
- (no location specified)
Sep 6, 2023
Mitapivat in Subjects With Sickle Cell Disease
Enrolling by invitation
- Sickle Cell Anemia
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)
Recruiting
- Sickle Cell Anemia
- Beta Thalassemia
- TBI
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Secondary Pulmonary Hypertension in Sickle Cell Anemia
Completed
- Pulmonary Hypertension
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Sickle Cell Anemia Trial in Santo Domingo (Hydroxyurea, TCD examination)
Active, not recruiting
- Sickle Cell Anemia
- Hydroxyurea
- TCD examination
-
Santo Domingo, Dominican RepublicEncargada del Servicio de Hematología-Oncología Hospital Infanti
Jan 17, 2023
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Bone Pain in Adults With Sickle Cell Disease
Recruiting
- Sickle Cell Disease
- +10 more
-
Sacramento, CaliforniaUC Davis Comprehensive Cancer Center
Nov 3, 2022
Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)
Active, not recruiting
- Sickle Cell Anemia
- PBSC Transplant
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022
Healthy, Sickle Cell Anemia Trial in United States (Placebo, PF-07209326)
Recruiting
- Healthy
- Sickle Cell Anemia
- Placebo
- PF-07209326
-
New Haven, Connecticut
- +11 more
Oct 10, 2022
Sickle Cell Disease, Sickle Cell Anemia, Insomnia Trial run by the National Cancer Institute (NCI) (ACT Intervention, Waitlist)
Not yet recruiting
- Sickle Cell Disease
- +6 more
- ACT Intervention
- Waitlist
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Biotin label
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)
Not yet recruiting
- Beta-Thalassemia
- +6 more
- CTX001
- (no location specified)
Jul 26, 2022
Stroke Prevention in Young Adults With Sickle Cell Anemia
Active, not recruiting
- Sickle Cell Disease
- +5 more
- Hydroxyurea therapy per standard care
-
Nashville, Tennessee
- +1 more
Jul 13, 2022
Sickle Cell Anemia Trial in Paris (Montreal cognitive assessment)
Not yet recruiting
- Sickle Cell Anemia
- Montreal cognitive assessment
-
Paris, FranceInternal Medicine Department - Tenon
May 20, 2022
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Sickle Cell Disease, Stroke, Neurologic Manifestations Trial in Nashville, Kano (This study does not entail offering any
Active, not recruiting
- Sickle Cell Disease
- +5 more
- This study does not entail offering any intervention; all data collected will be based on standard of care.
-
Nashville, Tennessee
- +2 more
Apr 14, 2022
Sickle Cell Anemia, Children, Only Trial in United States (Hydroxyurea SDM Toolkit, Clinician Pocket Guide)
Recruiting
- Sickle Cell Anemia
- Children, Only
- Hydroxyurea SDM Toolkit
- Clinician Pocket Guide
-
Oakland, California
- +10 more
Feb 9, 2022
Sickle Cell Disease, Sickle Cell Anemia, Stroke Trial in Kano (Moderate Dose Hydroxyurea, Low Dose Hydroxyurea)
Completed
- Sickle Cell Disease
- +2 more
- Moderate Dose Hydroxyurea
- Low Dose Hydroxyurea
-
Kano, Nigeria
- +1 more
Jan 16, 2022
Sickle Cell Anemia, Severe Acute Malnutrition Trial in Nashville, Kano (hydroxyurea (20mg/kg/day), Nutritional Supplement)
Recruiting
- Sickle Cell Anemia
- Severe Acute Malnutrition
- hydroxyurea (20mg/kg/day)
- Nutritional Supplement
-
Nashville, Tennessee
- +2 more
Dec 8, 2021
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Chart Review
- Survey
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 8, 2021
HbS Disease, Hemoglobin S Disease, Sickle Cell Anemia Trial in Austria, Germany (TCRa/ß+ and CD19+ depleted haploidentical stem
Recruiting
- HbS Disease
- +5 more
- TCRα/β+ and CD19+ depleted haploidentical stem cell transplantation
- Matched sibling donor transplantation
-
Düsseldorf, Germany
- +4 more
Jul 29, 2021